Implantable Element Compounds for Immune Response Modulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing implanted devices face challenges in modulating the immune response of the recipient, affecting their functionality and efficacy.
Innovation Solution
Development of compounds and compositions that can upregulate or downregulate the immune response by incorporating specific chemical structures, such as those described by Formula (I), which are covalently attached to implantable elements to interact with the biological immune response pathways.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If implanted devices are introduced to treat diseases or disorders, then therapeutic function is provided, but the biological immune response may reduce the fidelity and function of these devices
Solution Approach 1:
The patent applies the intermediary principle by introducing compounds that act as mediators between the implanted device and the biological immune system. These compounds modulate the immune response to be more favorable toward the implant, thereby resolving the contradiction between maintaining device function and overcoming immune rejection. The compounds serve as a bridge that translates the presence of the foreign device into an accepted biological response.
Solution Approach 2:
The patent employs parameter changes by modifying the biological immune response parameters through pharmacological intervention. By administering specific compounds that alter immune system behavior (changing the parameters of immune cell activity, cytokine production, and inflammatory response), the patent transforms the harmful immune response into a beneficial one that preserves device fidelity and function.
2Reliability
If compounds are developed to modulate immune response, then device function is enhanced, but complexity of the treatment regimen increases
Solution Approach 1:
The patent applies universality by developing compounds with broad immunomodulatory effects that can address multiple aspects of the immune response simultaneously. Rather than requiring separate treatments for different immune mechanisms, these multi-functional compounds can modulate various immune pathways (inflammation, cell-mediated immunity, humoral immunity) through a single therapeutic agent, thereby enhancing device function while minimizing regimen complexity.
Data Source
AI summary
The present invention provides compounds, e.g., compounds of Formula (I) and pharmaceutically acceptable salts, solvates, hydrates, tautomers, stereoisomers, isotopically labeled derivatives, and compositions thereof. Also provided are implantable elements (e.g., devices and materials) comprising the same, as well as methods of use thereof, e.g., for treating or preventing a disease, disorder, or condition.